SavedAdd your journal

Journals / Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi / 2000 / Cilt: 1 - Sayı: 3

Treatment of erectile dysfunction with sildenafil: Our first results

Erektil disfonksiyon tedavisinde sildenafilin etkinliği: İlk sonuçlarımız

Mehmet DÜNDAR
İzzet KOÇAK
Oruç Sema DÜNDAR
Tarkan TEKTEN
Pages
17–19
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A total of 29 out of 41 (70.3%) patients reported improved erections sufficient for vaginal penetration according to the responses to questions 3 and 4 of the IIEF (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, the efficacy and tolerability of sildenafil were evaluated using the self-administered International Index of Erectile Function (IIEF) questionnaire in patients with erectile dysfunction (ED).
📊
Key Findings & Data:Patients were instructed to take 50 mg sildenafil as needed but not more than one dose daily.
💡
Conclusion & Impact:A total of 29 out of 41 (70.3%) patients reported improved erections sufficient for vaginal penetration according to the responses to questions 3 and 4 of the IIEF (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, the efficacy and tolerability of sildenafil were evaluated using the self-administered International Index of Erectile Function (IIEF) questionnaire in patients with erectile dysfunction (ED). Fifty-six patients suffering from ED at least one year duration were enrolled in the study. All patients underwent a complete urological, ophtalmological and cardiac work-up, intracavernous injection of papaverine and penile Doppler ultrasound examination. Patients were instructed to take 50 mg sildenafil as needed but not more than one dose daily. After 8 weeks of treatment, patients were revisited and the efficacy of sildenafil was assessed according to the changes of IIEF. Forty-one (73%) patients completed the study the reasons for incompletion were adverse effect in 3 (5.3%) patients, insufficient clinical response in 4 (7.1%) and lost of follow-up in 8 (14.2%). A total of 29 out of 41 (70.3%) patients reported improved erections sufficient for vaginal penetration according to the responses to questions 3 and 4 of the IIEF (p

Özet

Bu çalışmada, erektil disfonksiyon (ED) tedavisinde sildenafilin etkinlik ve güvenilirliği, hastaların ereksiyon işlevi uluslararası soru (IIEF) formuna verdiği yanıtlara göre değerlendirilmiştir. Polikliniğimize en az 1 yıldır süren yakınmalarla başvurup ED tanısı alan, toplam 56 hasta çalışma kapsamına alındı. Olgular Üroloji, Kardiyoloji, ve Göz Hastalıkları bölümleri tarafından incelendi. İntrakavernöz papaverin enjeksiyonu ve penil Doppler inceleme ile değerlendirildi. Hastalara günde birden fazla olmamak koşuluyla 50 mg sildenafil tedavisi başlandı. 8 haftalık tedavi sonrasında tedavinin etkinliği, olguların IIEF formuna verdikleri yanıtlardaki değişime göre değerlendirildi. Çalışma 3 (%5.3) hastada yan etki, 4 (%7.1) hastada yetersiz cevap ve 8 (%14.2) hastada ise takipsizlik nedeniyle toplam 41 (%73) hasta ile tamamladı. Bunlardan 29 hasta (%70.3) IIEF form 3 ve 4'e verilen yanıtlara göre ilişki için yeterli kalitede, sürdürebilen ereksiyonun oluştuğunu bildirdi (p

🔖

Cite This Article

DÜNDAR, M., KOÇAK, İ., DÜNDAR, O. S., TEKTEN, T. (2022). Treatment of erectile dysfunction with sildenafil: Our first results. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 1 - Sayı: 3, 17–19. https://ajindex.com/articles/429157

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. NIH. Consensus development panel on impotance.Impotance.JAMA1993; 270: 83-90. 2.Wagner G, Saenz de Tejada I. Update on male erectile dysfunction.BMJ199828; 316: 678-82. 3.Boolel M, Gepi-Attee S, Gingell JC, Allen MJ.Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78: 257-261. 4.Hanash KA. Comparative results of goal orianted therapy for erectile dysfunction. J Urol 1997; 157:2135-2138. 5.Jarow JP, Nana Sinkam P, Sabbagh M, Eskew A.Outcame analysis of goal directed therapy for impotance J Urol 1996; 155: 1609-1612. 6.Montegue DK, Barada JR, Belker AM et al. Clinical Guidelines Panel on Erectile Dysfunction: summary report on the treatment of organic erectile dysfunction.J Urol 1996; 156: 2007-2011. 7.Goldstein I, Lue TF, Padma-Nathan H, Rosen RC,Steers WO,Wicher PA. Oral sildenafil treatment in the treatment of erectile dysfunction. N Eng J Med 1998; 338: 1397-1404. 8.Langtry HD, Markham A. Sildenafil: a review of its use in erectile dysfunction. Drugs 1999; 57(6): 967-89 9.Boolell M, Pearson J, Gingell JC, et al. Sildenafil (Viagra) is an efficacious oral therapy in diabetic patients with erectile dysfunction. Int J Impot Res 1996; 8: 186-89. 10. Rosen RC, Riley A, Wagner G, Osterloh IH,Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49(6):822-30.